Project 2: Maternal history of childhood sexual abuse and adverse perinatal outcomes: Harnessing novel ecological methods to understand mechanisms

项目 2:母亲童年性虐待史和不良围产期结局:利用新的生态方法来了解机制

基本信息

  • 批准号:
    10090780
  • 负责人:
  • 金额:
    $ 21.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-15 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMAY / ABSTRACT 1 in 5 women in obstetric care experienced sexual abuse in childhood. Women with histories of child sexual abuse are 2x more likely to experience hypertensive disorders of pregnancy (HDP), a leading cause of maternal and fetal morbidity and mortality in the United States. $2.18 billion is spent annually on treatment of affected mothers and infants in the year after delivery. In addition, HDP increases lifetime cardiac disease risk by 2-4X and is considered an independent, gender-specific cardiovascular risk factor by the American Heart Association. Identification of treatment targets for the prevention of HDP holds tremendous promise in the prevention of cardiovascular diseases later in life. Maternal history of child sexual abuse is hypothesized to increase risk for HDP through stress-induced activation of the autonomic nervous system. Routine prenatal experiences, including prenatal care appointments, pregnancy symptoms, and fetal movements, may be a significant source of stress for women with child sexual abuse histories as these experiences can serve as disturbing reminders of previous sexual abuse. Therefore, perceptions of bodily sensations (i.e., interoception), may trigger autonomic stress responses and increase risk for HDP among women with child sexual abuse histories. Conversely, consistent with the stress buffering model, supportive social context may interrupt interoceptive perceptions and decrease autonomic activation for women with child sexual abuse histories. The objective of the proposed study is to characterize interoceptive and autonomic responses to prenatal experiences as pathways to HDP in women with and without CSA histories, and to examine the moderating role of social context. We will use a novel methodological approach by integrating EMA, ambulatory biometric wearable technology, and electronically activated recorder (EAR) methods to rigorously assess daily interoceptive and autonomic responses to prenatal experiences across gestation. Results from this area of research are expected to have an important positive impact on the field because new knowledge may be used to select meaningful targets for interventions to regulate blood pressure and the development of HDP, and to prevent cardiovascular illness later in life.
项目摘要/摘要 在产科护理的妇女中,每5人中就有1人在童年经历过性虐待。有儿童性行为史的女性 虐待的人患妊娠期高血压疾病(HDP)的可能性要高出2倍,这是 美国的孕产妇和胎儿发病率和死亡率。每年花费21.8亿美元用于治疗 受影响的母亲和婴儿在产后一年。此外,HDP会增加终生心脏病风险 2-4倍,被美国心脏协会认为是独立的、特定于性别的心血管危险因素 协会。确定预防HDP的治疗目标在以下方面具有巨大的希望 预防晚年心血管疾病。儿童性虐待的母亲病史被假设为 通过应激诱导的自主神经系统的激活,增加患HDP的风险。常规产前检查 经历,包括产前护理预约、怀孕症状和胎儿移动,可能是一种 对于有儿童性虐待史的妇女来说,这是一个重要的压力来源 令人不安的前性虐待事件。因此,身体感觉的知觉(即,内感), 可能在儿童性虐待妇女中触发自主应激反应并增加HDP的风险 历史。相反,与压力缓冲模型一致,支持性的社会背景可能会打断 对有儿童性虐待史的妇女来说,感觉间知觉和自主神经激活减少。这个 本研究的目的是描述产前的内感和自主神经反应的特征。 在有和没有CSA病史的女性中作为HDP途径的经历,并检查缓和 社会背景的作用。我们将使用一种新的方法,将EMA、动态生物识别 可穿戴技术和电子激活记录器(EAR)方法严格评估日常工作 怀孕期间对产前经历的感觉间和自主神经反应。这一领域的结果 预计研究将对该领域产生重要的积极影响,因为可能会使用新的知识 选择有意义的干预目标,以调节血压和HDP的发展,并 在以后的生活中预防心血管疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margaret Bublitz其他文献

Margaret Bublitz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margaret Bublitz', 18)}}的其他基金

Mechanisms of mindfulness training to prevent hypertensive disorders of pregnancy
正念训练预防妊娠期高血压疾病的机制
  • 批准号:
    10634751
  • 财政年份:
    2021
  • 资助金额:
    $ 21.7万
  • 项目类别:
Mechanisms of mindfulness training to prevent hypertensive disorders of pregnancy
正念训练预防妊娠期高血压疾病的机制
  • 批准号:
    10772285
  • 财政年份:
    2021
  • 资助金额:
    $ 21.7万
  • 项目类别:
Mechanisms of mindfulness training to prevent hypertensive disorders of pregnancy
正念训练预防妊娠期高血压疾病的机制
  • 批准号:
    10178903
  • 财政年份:
    2021
  • 资助金额:
    $ 21.7万
  • 项目类别:
Mechanisms of mindfulness training to prevent hypertensive disorders of pregnancy
正念训练预防妊娠期高血压疾病的机制
  • 批准号:
    10477199
  • 财政年份:
    2021
  • 资助金额:
    $ 21.7万
  • 项目类别:

相似海外基金

Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
  • 批准号:
    10679938
  • 财政年份:
    2023
  • 资助金额:
    $ 21.7万
  • 项目类别:
Hepatocytes Encapsulated with mesenchymal stromal cells in alginate microbeads for the treatment of acute Liver failure in Paediatric patients (HELP)
将间充质基质细胞封装在藻酸盐微珠中的肝细胞用于治疗儿科患者的急性肝衰竭(HELP)
  • 批准号:
    MR/V038583/1
  • 财政年份:
    2022
  • 资助金额:
    $ 21.7万
  • 项目类别:
    Research Grant
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
  • 批准号:
    10421290
  • 财政年份:
    2021
  • 资助金额:
    $ 21.7万
  • 项目类别:
Development of the innovative treatment using self iPS cell for acute liver failure
开发利用自身 iPS 细胞治疗急性肝衰竭的创新疗法
  • 批准号:
    21K08685
  • 财政年份:
    2021
  • 资助金额:
    $ 21.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
  • 批准号:
    10180251
  • 财政年份:
    2021
  • 资助金额:
    $ 21.7万
  • 项目类别:
Therapeutic effect of plasmacytoid dendritic cells transplantation for acute liver failure
浆细胞样树突状细胞移植治疗急性肝衰竭的疗效
  • 批准号:
    20K21607
  • 财政年份:
    2020
  • 资助金额:
    $ 21.7万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Macrophage Therapy for Acute Liver Failure
巨噬细胞治疗急性肝衰竭
  • 批准号:
    MR/T044802/1
  • 财政年份:
    2020
  • 资助金额:
    $ 21.7万
  • 项目类别:
    Research Grant
Investigation of an optimal environment for the proliferation of mature hepatocytes toward the rescue of acute liver failure patients
研究成熟肝细胞增殖的最佳环境以挽救急性肝衰竭患者
  • 批准号:
    19K08475
  • 财政年份:
    2019
  • 资助金额:
    $ 21.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
小儿急性肝衰竭 (PALF) 免疫介导病理生理学治疗 (TRIUMPH)
  • 批准号:
    9789253
  • 财政年份:
    2018
  • 资助金额:
    $ 21.7万
  • 项目类别:
Cryopreservation of hiPS-derivd hepatic progenitor cells and application to acute liver failure treatment
hiPS源性肝祖细胞的冷冻保存及其在急性肝衰竭治疗中的应用
  • 批准号:
    18K08662
  • 财政年份:
    2018
  • 资助金额:
    $ 21.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了